The UK government has recently published a summary of public responses to its Call for Evidence, which it launched in February with the intention of collating multi-disciplinary input from health and security experts to help shape the UK’s biological security strategy (see further here). The response closed on April 1, with 118 responses received from … Read more
Using artificial intelligence (AI) for warfare has been the promise of science fiction and politicians for years, but new research from the Georgia Institute of Technology argues only so much can be automated and shows the value of human judgment. Using artificial intelligence (AI) for warfare has been the promise of science fiction and politicians … Read more
New York, United States:The Global Computational Biology Market is expected to grow at a CAGR of 9.71% and is poised to reach by 2027. The research study report by DECISIVE MARKETS INSIGHTS contains profiles of the leading industry players, SWOT analysis, and their market strategies. The study includes information on significant industry participants, including company … Read more
First there’s weakness and throbbing in the arm muscles that take on the immune-teaching chemicals. Then the fatigue and aches spread until your whole body is complaining. It turns out those of us who experience this reaction to the COVID-19 vaccines have markers in our blood that indicate a more active immune response, but a … Read more
According to a new study, switching the administration of mRNA-based COVID-19 vaccines from intramuscular to subcutaneous injection could ease adverse post-vaccination effects, such as fatigue. Mouse experiments suggest a switch from intramuscular to subcutaneous injection may ease fatigue. Currently, mRNA-based[{” attribute=””>COVID-19 vaccines are injected deep into the muscles, which is called intramuscular injection. An alternative … Read more
LOS ANGELES – One powerful way cancer cells defend against tumor-killing immune cells is to load up their cell surface with a protein known as PD-L1. Now a team of UCLA Jonsson Comprehensive Cancer Center researchers led by Roger S. Lo, MD, PhD, has identified a method to degrade tumor cell-surface PD-L1, thereby making tumors … Read more
Researchers from the CiQUS of the USC have just published an article that opens up a new immunotherapeutic path against cancer. The international study, led by the Center’s PI Eddy Sotelo and Andreas Lundqvist from Karolinska Institutet (link is external) in Sweden, also involves researchers from CiMUS and the USC (link is external) Faculty of … Read more
Tumors send out signals that impair normal blood flow, which makes them hard to treat with every type of cancer treatment, including radiation and chemo-, targeted and immunotherapy. Impaired blood supply creates an environment low in oxygen levels – hypoxia – that causes the tumors to take on aggressive characteristics and become immuno-suppressed. To address … Read more
Sowerby’s beaked whale. Credit: NOAA Fisheries An international team of biologists has successfully used biologists to reveal insights into the lifestyle and hunting behavior of the little-known species Sowerby’s beaked whale. The team’s first results show that these whales (which resemble dolphins) have a surprisingly different, much faster lifestyle than related species. The research was … Read more
(Memphis, Tenn. — May 9, 2022) EZH2 protein inhibitors are effective against cancers SMARCB1 mutations such as rhabdoid tumors in children. However, these drugs are subject to treatment resistance. Scientists at St. Jude Children’s Research Hospital have identified a novel drug target that may help overcome resistance to EZH2 inhibitors. A paper on the work … Read more